| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/18/2008 | CN101199518A Paediatrics amoxicillin Na dissolve sheet |
| 06/18/2008 | CN101199517A Mitozolomide controlled-release planting dose for treating entity tumor |
| 06/18/2008 | CN101199515A Hydrochloric acid benzydamine and preparing method thereof |
| 06/18/2008 | CN101199514A Ketoralac ammonia butanetriol injection and preparing method thereof |
| 06/18/2008 | CN101199511A Andrographis lactone self-emulsification capsule of antibacterial antiphlogistic |
| 06/18/2008 | CN101199510A Silybin precursor multiphase lipidosome pharmaceutics and preparing method thereof |
| 06/18/2008 | CN101199508A Salvianic phenol acid or salt phospholipid compound and preparing method thereof |
| 06/18/2008 | CN101199506A Oxaliplatin lyophilized powder injection and preparing method thereof |
| 06/18/2008 | CN101199505A Verapamil liposome and preparing method thereof |
| 06/18/2008 | CN101199499A Active controlled-release contraceptive emulsion |
| 06/18/2008 | CN101199496A Physical cross-bonding high molecular water resin Cataplasma substrate and preparing method thereof |
| 06/18/2008 | CN101199495A Patch of abstention containing cola stationary medicament and preparing method thereof |
| 06/18/2008 | CN101199494A Kinesia-prevention patch and preparing method thereof |
| 06/18/2008 | CN101199492A Application of oligomerization xylose and xylito in coating slice coating |
| 06/18/2008 | CN101199490A Sulphuric acid indene land leather slice and preparing method thereof |
| 06/18/2008 | CN101199485A Amino-glucose freeze drying-powder pin and its preparing method thereof |
| 06/18/2008 | CN101199483A Stable anti-HER2 humanized antibody preparation |
| 06/18/2008 | CN101199482A Process for preparing degradable polyester microsphere wrapping |
| 06/18/2008 | CN101199481A Process for preparing solid lipide nano particle |
| 06/18/2008 | CN101199480A Compounded propofol fat emulsion injection containing analgesics and process for preparing same |
| 06/18/2008 | CN101199479A Officinal submicro emulsion and process for preparing same |
| 06/18/2008 | CN101199478A Itraconazole freeze-dry emulsion and process for preparing same |
| 06/18/2008 | CN101199475A Lincomycin hydrochloride sustained-release preparation and process for preparing same |
| 06/18/2008 | CN101199474A Nifuratel gel and process for preparing same |
| 06/18/2008 | CN100394983C Doramectin injection fluid containing soyban oil |
| 06/18/2008 | CN100394982C Inflammation-resistant modified imvite and preparing method thereof |
| 06/17/2008 | USRE40387 7,11-dihydroxy 8,8,10,12,16-pentamethyl-3-(1-methyl-2-(2-methyl-4-thiazolyl) ethenyl-17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione and neutralizing buffer in an amount sufficient to reduce its decomposition; increasing the bioavailability of orally administered epothilones; anticarcinogenic agent |
| 06/17/2008 | US7388099 Hydroxycucurbituril derivatives, their preparation methods and uses |
| 06/17/2008 | US7388079 Delivery of pharmaceutical agents via the human insulin receptor |
| 06/17/2008 | US7388032 Sustained release compositions, process for producing the same and utilization thereof |
| 06/17/2008 | US7388026 Antitumor antibiotic; water solubility, stability; N-[2-{(1-chloromethyl)-1,2-dihydro-5-[(4-methylpiperazino)carbonyloxy]-3H-benz(e)indol-3-yl}carbonyl]-1H-indol-5-yl]-5-[(3-methyldithio-1-oxopropyl)-amino]-1H-indole-2-carboxamide |
| 06/17/2008 | US7387994 Antitumor, anticancer agents; particles or coils or stents coated solid-phase agent comprising a binding agent comprising collagen are directed to target vasculature, such as the vasculature of solid tumor masses or aneurysms |
| 06/17/2008 | US7387900 Colloidal metal compositions and methods |
| 06/17/2008 | US7387806 Method of using geranium oil and sophora root extracts as a supporting composition in cancer treatments |
| 06/17/2008 | US7387796 Stable compositions of S-adenosyl-l-methionine with dextran |
| 06/17/2008 | US7387794 Preparation of powder agglomerate |
| 06/17/2008 | US7387792 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| 06/17/2008 | US7387791 Oral administering; tablet with enteric coating; supplying drug to gastrointestinal systems |
| 06/17/2008 | US7387790 Non-gas containing nanoparticles comprising a mixture of select lipids capable of being internalized within a targeted tissue or cell sufficient to achieve a desired effect; anticancer agents |
| 06/17/2008 | US7387789 Transdermal delivery of non-steroidal anti-inflammatory drugs |
| 06/17/2008 | US7387787 Mixture of polymer, polyvinyl alcohol, propylene glycol, humectant,cleaningh compound for skin; generating foam upon exposure to water |
| 06/17/2008 | US7387786 Food additive compositions containing sterol esters, solubilizing agents, dispersants and antioxidants |
| 06/17/2008 | US7387771 dissolving in carrier liquid; drug linked to a protein-binding molecule via a spacer which is cleaved hydrolytically or enzymatically in the body of a subject in a pH-dependent manner; tissue targeted delivery; Doxorubicin-phenylacetylhydrazone spacer-maleimide |
| 06/17/2008 | US7387623 Injectable pharmaceutical suspension in a two-chamber vial |
| 06/17/2008 | CA2439818C Large, porous particles produced controlling humidity during a spray drying process |
| 06/17/2008 | CA2414063C Highly concentrated stable meloxicam solutions |
| 06/17/2008 | CA2384188C Antiviral compositions |
| 06/17/2008 | CA2350220C Antioxidant composition comprising propionyl l-carnitine and a flavonoid against thrombosis and atherosclerosis |
| 06/17/2008 | CA2331076C Stable carbanilide composition |
| 06/17/2008 | CA2306566C Low temperature coatings |
| 06/17/2008 | CA2303884C Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 06/17/2008 | CA2294457C Pharmaceutical composition for application to mucosa |
| 06/17/2008 | CA2279788C Cation exchange resin preparation |
| 06/17/2008 | CA2274852C Method of coupling polysaccharides to proteins |
| 06/17/2008 | CA2251886C An oral pharmaceutical formulation containing ibandronate |
| 06/17/2008 | CA2200189C Scopolamine plaster |
| 06/17/2008 | CA2189051C Composition for delivery of toxic radioisotopes to the cell nucleus and use |
| 06/17/2008 | CA2182199C Formulations for il-11 |
| 06/17/2008 | CA2177667C Mammalian vaccine compositions comprising squalene or squalane, lecithin and a polyoxyethylene sorbitan ester as an adjuvant |
| 06/17/2008 | CA2166388C Antifungal composition for external use retentive in stratum corneum |
| 06/17/2008 | CA2102693C Protein formulation comprising growth hormone |
| 06/17/2008 | CA2100394C Cosmetic sunscreen |
| 06/14/2008 | CA2613409A1 Protein stabilization formulations |
| 06/13/2008 | CA2614162A1 Tissue fusion method using collagenase for repair of soft tissue |
| 06/12/2008 | WO2008070698A1 A controlled release enzymatic composition and methods of use |
| 06/12/2008 | WO2008070402A2 Intraocular drug delivery systems |
| 06/12/2008 | WO2008070384A2 Method of preparing macromolecular contrast agents and uses thereof |
| 06/12/2008 | WO2008070347A2 Betulin-peptide conjugates |
| 06/12/2008 | WO2008070165A1 Drug-containing compositions and their use |
| 06/12/2008 | WO2008070149A2 Prodrugs and methods of making and using the same |
| 06/12/2008 | WO2008069283A1 Pharmaceutical composition for external application and adhesive skin patch |
| 06/12/2008 | WO2008069262A1 Film-coated preparation having improved stability |
| 06/12/2008 | WO2008069020A1 Method for improving solubility of protein, method for stabilizing dissolved state of protein-containing aqueous solution, and composition |
| 06/12/2008 | WO2008068982A1 Adjuvant for gene transfer comprising cell migration peptide as the active ingredient and gene transfer method using the adjuvant for gene transfer |
| 06/12/2008 | WO2008068945A1 Gene transfer aid comprising peptide capable of migrating into cell as active ingredient, and gene transfer method utilizing the gene transfer aid |
| 06/12/2008 | WO2008068939A1 Organic-inorganic hybrid particles containing contrast agent |
| 06/12/2008 | WO2008068885A1 Protecting agent for use in lyophilization and method for production of physiologically active substance |
| 06/12/2008 | WO2008068427A2 Anti-microorganism terpenic composition |
| 06/12/2008 | WO2008068276A1 Soft gelatin capsules comprising acetylsalicylic acid |
| 06/12/2008 | WO2008067865A1 Package |
| 06/12/2008 | WO2008067670A1 Tablets comprising entacapone and crospovidone |
| 06/12/2008 | WO2008067613A1 Liposome production |
| 06/12/2008 | WO2008049178A8 Stable and ready-to-use oil-in-water propofol microemulsion |
| 06/12/2008 | WO2008049020A3 Diclofenac gel |
| 06/12/2008 | WO2008043601A3 Transdermal therapeutic system with two-phase releasing profile |
| 06/12/2008 | WO2008036809A3 Methods and materials for reducing risk of cold and/or flu |
| 06/12/2008 | WO2007144709A3 Leptomycin derivatives |
| 06/12/2008 | WO2007132338A3 IL-1α IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS |
| 06/12/2008 | WO2007118653A3 Nanoparticle containing nicotine and/or cotinine, dispersions and use thereof |
| 06/12/2008 | WO2007078726A3 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| 06/12/2008 | US20080140185 Biodegradable and Biocompatible Peg-Based Poly(Ester-Urethanes) |
| 06/12/2008 | US20080139815 Drug conjugates |
| 06/12/2008 | US20080139786 Exposing azo, azide and sulfenate agents to visible or infrared light; use in medical procedures to cause necrosis or apoptosis of tissue |
| 06/12/2008 | US20080139785 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 06/12/2008 | US20080139672 Oil miscible glycols combined with organic and/or inorganic acid components; reduced irritation; lower cost; free of formaldehyde donors, parabens, ethanols and isothiazolinones; antimicrobial and fungicidal activities |
| 06/12/2008 | US20080139671 Applying clear liquid collagen and riboflavin crosslinker solution to eye tissue; exposing in situ to ultraviolet radiation dosages; reconstructing and strengthening |
| 06/12/2008 | US20080139670 Drug Delivery System |
| 06/12/2008 | US20080139666 Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxy Stilbenes and Novel Stilbene Derivatives and Analogues |
| 06/12/2008 | US20080139522 Dexamethasone disodium phosphate;xanthan gum; sodium (di)hydrogen phosphate buffer; sodium citrate; and water; ophthalmology; vision defects; corneal epithelial cells; wound healing agents |
| 06/12/2008 | US20080139503 Inhibiting FGF growth factor with heparins; antitumor agents; angiogenesis inhibitor; antidiabetic agent treating diabetic retinopathy; antiinflammatory agent; treating retrolenticular fibroplasia, psoriasis, restenosis after angioplasty and after coronary by-pass; drug delivery |